How secure is wegovy's data storage?

I don’t have access to Novo Nordisk’s internal security docs for Wegovy. Public information usually states that healthcare apps and patient portals use standard, enterprise-grade security, but exact protections can vary by country and by how you’re using Wegovy (mobile app vs. provider portal vs. website).

What Wegovy-like data storage typically protects
- Encryption in transit: data protected when it travels between your device and servers (TLS/HTTPS).
- Encryption at rest: data stored on servers is encrypted (often AES-256).
- Access controls: only authorized staff and systems can access data, with least-privilege and logging.
- Authentication: user accounts with secure login; some setups offer multi-factor authentication.
- Vendor risk and BAAs: third-party service providers are managed carefully; HIPAA/business associate agreements may apply if PHI is involved.
- Data minimization and retention: data kept only as long as needed and deleted when appropriate.
- Compliance: in the US, PHI is subject to HIPAA; in the EU/UK, GDPR applies; privacy notices usually reference these protections.

How you can verify and improve your own security
- Read the Wegovy privacy policy and any security whitepapers or user security pages they provide (look for sections on encryption, data sharing, retention, and user rights).
- Check if the app supports multi-factor authentication and enable it if available.
- Review what data you’re sharing with third parties or providers; minimize data you don’t need to share.
- Ensure your device is secure (screen lock, device encryption, up-to-date OS) since app data on your device also matters.
- If you’re in the US, ask whether a Business Associate Agreement (BAA) covers any PHI stored or processed by Wegovy; if you’re in the EU/UK, review GDPR-related notices.

If you’d like, tell me your country and whether you’re asking about the mobile app, a provider portal, or a consumer website. I can guide you to the specific privacy/security pages or help you draft questions for Novo Nordisk’s privacy contact.